Assessment of lithogenic risk in children based on a morning spot urine sample.
OBJECTIVE
The Bonn Risk Index has been used to evaluate the risk of urinary calcium oxalate stone formation. According to the original method, risk should be determined based on 24-hour urine collection. We studied whether the Bonn Risk Index could be measured in spot urine samples and which part of the day is most suitable for this purpose.


METHODS
We collected total and fractionated 24-hour urine (in a 6-hour nocturnal portion and 9 consecutive 2-hour diurnal samples) in 42 children and adolescents with calcium oxalate urolithiasis and 46 controls. Bonn Risk Index values determined from each of the urine fractions were compared to those obtained from related 24-hour urine collections.


RESULTS
Both groups exhibited similar circadian patterns of Bonn Risk Index values. Median Bonn Risk Index for the nighttime portion of urine in the stone group was 1.4 times higher than that obtained from the total 24-hour urine. The morning hours between 08:00 and 10:00 showed the peak lithogenic risk, and this fraction had the highest sensitivity and selectivity regarding discrimination between stone formers and healthy subjects. The afternoon hours demonstrated lower and less fluctuating crystallization risk. Despite diurnal fluctuations in Bonn Risk Index, there was still a well-defined cutoff between the groups.


CONCLUSIONS
Bonn Risk Index determined from urine samples collected between 08:00 and 10:00 appears optimal in separating stone formers from healthy subjects, and appears as useful as the value determined from 24-hour urine collection. Investigation of this diurnal sample simplifies diagnosis in pediatric stone disease without loss of clinical information.
Porowski
Tadeusz
T
Department of Pediatric Nephrology, Medical University of Bialystok, Bialystok, Poland. tporowski@biaman.pl
Kirejczyk
Jan K
JK
Zoch-Zwierz
Walentyna
W
Konstantynowicz
Jerzy
J
Korzeniecka-Kozerska
Agata
A
Motkowski
Radosław
R
Laube
Norbert
N
D000293:Adolescent; D002129:Calcium Oxalate / Q000032:analysis; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D008297:Male; D012372:ROC Curve; D018570:Risk Assessment; D052878:Urolithiasis / Q000652:urine*
D002129:Calcium Oxalate